Clavimox Powder For Oral Susp 457 Mg 75 ml

Clavimox Powder For Oral Susp 457 Mg 75 ml

Description:

Clavimox Powder For Oral Suspension 457 mg 75 ml is a prescription systemic antibiotic medicine used to treat a wide range of bacterial infections in adults and children. It contains the combination of amoxicillin and clavulanic acid, which work together to kill bacteria and overcome resistance caused by beta-lactamase–producing organisms. After reconstitution with water, it forms an oral suspension that is taken by mouth, making it suitable for patients who have difficulty swallowing tablets, especially children. This product is manufactured by Pharco and is commonly used for respiratory, ear, sinus, skin, and urinary tract infections as directed by a healthcare professional.

Indications:

• Lower respiratory tract infections, including bronchitis and pneumonia, caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial otitis media (middle ear infection) caused by beta-lactamase–producing Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial sinusitis caused by beta-lactamase–producing Haemophilus influenzae and Moraxella catarrhalis.
• Skin and skin structure infections caused by beta-lactamase–producing Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary tract infections (UTIs) caused by beta-lactamase–producing Escherichia coli, Klebsiella species, and Enterobacter species.
• Other susceptible infections as determined by culture and sensitivity and as prescribed by a physician.
• Indicated only for bacterial infections; not effective for viral infections such as common cold or influenza.

Active Ingredients / Key Components:

• Amoxicillin – exact concentration per 5 ml in this 457 mg/5 ml formulation is not specified in the available data.
• Clavulanic acid (as potassium clavulanate) – exact concentration per 5 ml in this 457 mg/5 ml formulation is not specified in the available data.
• Each 5 ml of reconstituted oral suspension provides a total of 457 mg of amoxicillin–clavulanic acid combination; the precise ratio of amoxicillin to clavulanic acid in this specific product is not available in the provided information.
• Excipients: flavoring agents, sweeteners, stabilizers, and suspending agents (full excipient list and their concentrations , please check the product leaflet or the manufacturer’s official website).

Dosage & Administration / How to Use:

• This product is a powder that must be reconstituted with water by the pharmacist or according to the package instructions to prepare the oral suspension.
• Shake the bottle well before each dose to ensure uniform suspension.
• Use the provided measuring cup or oral syringe to measure the prescribed dose accurately; do not use household teaspoons.
• Typical dosing is based on body weight in children and on infection severity in adults; the exact dose, frequency, and duration must be determined by the prescribing physician.
• Usually taken every 8–12 hours (2–3 times daily) with food to improve absorption and reduce gastrointestinal side effects; follow your doctor’s specific instructions.
• Complete the full course of therapy even if symptoms improve early to prevent relapse and antibiotic resistance.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose; do not double the dose to make up for a missed one.
• For pediatric use, dosing must always be calculated and supervised by a pediatrician.

Clinical Benefits:

• Broad-spectrum antibacterial activity against many gram-positive and gram-negative organisms, including beta-lactamase–producing strains.
• Combination of amoxicillin with clavulanic acid helps overcome bacterial resistance by inhibiting beta-lactamase enzymes.
• Effective in treating common community-acquired respiratory infections such as bronchitis, pneumonia, sinusitis, and otitis media.
• Provides reliable treatment for skin and soft tissue infections and urinary tract infections caused by susceptible organisms.
• Oral suspension form facilitates easier administration in children and adults who cannot swallow tablets.
• When used appropriately, helps shorten the duration of infection, relieve symptoms such as fever, pain, and inflammation, and prevent complications.

Warnings & Contraindications:

• Contraindicated in patients with a known hypersensitivity or allergy to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation.
• Use with caution in patients with a history of severe allergic reactions to cephalosporins or other beta-lactam antibiotics due to possible cross-sensitivity.
• Use with caution in patients with hepatic impairment or history of liver dysfunction associated with amoxicillin–clavulanic acid; liver function monitoring may be required.
• Use with caution in patients with renal impairment; dose adjustment may be necessary as directed by a physician.
• Prolonged use may result in overgrowth of non-susceptible organisms, including fungi; if superinfection occurs, appropriate measures should be taken.
• May cause antibiotic-associated colitis, including Clostridioides difficile–associated diarrhea; discontinue and seek medical advice if severe or persistent diarrhea occurs.
• Consult your doctor before use if pregnant or nursing; use only if clearly needed and prescribed by a healthcare professional.
• Consult your doctor before use if you are taking other medications, especially anticoagulants (e.g., warfarin), allopurinol, methotrexate, or other antibiotics, due to potential interactions.
• Patients with phenylketonuria or specific metabolic disorders should check excipients with their doctor or pharmacist.
• Not intended for self-medication; use only under medical supervision and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects: nausea, vomiting, diarrhea, abdominal discomfort, and mild skin rash.
• Less common side effects: headache, dizziness, oral or vaginal candidiasis (thrush), and changes in taste.
• Allergic reactions can occur, including itching, hives, and skin eruptions; discontinue use and seek medical advice if these appear.
• Serious side effects (seek immediate medical attention): severe allergic reaction (anaphylaxis) with difficulty breathing, swelling of face or throat, severe skin reactions, yellowing of skin or eyes (jaundice), dark urine, severe or bloody diarrhea, or persistent vomiting.
• Liver enzyme elevations and hepatitis have been reported rarely with amoxicillin–clavulanic acid combinations.

Storage Instructions:

Store the unopened powder in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. After reconstitution, the oral suspension should typically be stored in a refrigerator and used within the period specified in the package insert (exact in-use shelf life is not available in the provided information; follow the label and pharmacist’s instructions). Do not freeze. Discard any unused suspension after the recommended period.

Specifications:

• Product type: Prescription systemic antibiotic oral suspension.
• Form: Powder for oral suspension to be reconstituted with water.
• Strength: 457 mg of amoxicillin–clavulanic acid combination per 5 ml (exact ratio of components not available in the provided information).
• Pack size: 75 ml of reconstituted suspension (after adding water as directed).
• Route of administration: Oral.
• Suitable for: Adults and children as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.